Copyright
©The Author(s) 2019.
World J Cardiol. Jan 26, 2019; 11(1): 13-23
Published online Jan 26, 2019. doi: 10.4330/wjc.v11.i1.13
Published online Jan 26, 2019. doi: 10.4330/wjc.v11.i1.13
Component | Score | Description | ||
W | 0 | No ulcer (ischemic rest pain) | ||
1 | Small, shallow ulcer on distal leg or foot without gangrene | |||
2 | Deeper ulcer with exposed bone, joint or tendon ± gangrenous changes limited to toes | |||
3 | Extensive deep ulcer, full thickness heel ulcer ± calcaneal involvement ± extensive gangrene | |||
I | ABI | Ankle pressure (mmHg) | Toe pressure or TcPO2 | |
0 | ≥ 0.80 | > 100 | ≥ 60 | |
1 | 0.6-0.79 | 70-100 | 40-59 | |
2 | 0.4-0.59 | 50-70 | 30-39 | |
3 | < 0.40 | < 50 | < 30 | |
FI | 0 | No symptoms or signs of infection | ||
1 | Local infection involving only skin and subcutaneous tissue | |||
2 | Local infection involving deeper than skin/subcutaneous tissue | |||
3 | Systemic inflammatory response syndrome |
- Citation: Spiliopoulos S, Vasiniotis Kamarinos N, Brountzos E. Current evidence of drug-elution therapy for infrapopliteal arterial disease. World J Cardiol 2019; 11(1): 13-23
- URL: https://www.wjgnet.com/1949-8462/full/v11/i1/13.htm
- DOI: https://dx.doi.org/10.4330/wjc.v11.i1.13